FDA Warning Letter — SURGENEX LLC

Case 615254 — FEI 3011692533

The FDA took a Warning Letter action against SURGENEX LLC on November 15, 2021 (Scottsdale, AZ). The action was issued by CBER and concerns biologics products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
SURGENEX LLC
Date
November 15, 2021
Fiscal Year
2022
Product Type
Biologics
Center
CBER
Location
Scottsdale, AZ (United States)